Evidence map›Paper›PMID 30298683›Full record

ArticleMolecular oral microbiology2018

Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.

Meng-Hsuan Ho, Richard J Lamont, Walter J Chazin, Huiqing Chen, Daphne F Young, Prashant Kumar, Hua Xie

Abstract read
In one paragraph

Article in Molecular oral microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Meng-Hsuan HoDepartment of Oral Biology, Meharry Medical College, Nashville, Tennessee.
Richard J LamontDepartment of Oral Immunology and Infectious Diseases, University of Louisville, Louisville, Kentucky.ORCID 0000-0002-3147-5039
Walter J ChazinDepartment of Biochemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Huiqing ChenDepartment of Biochemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Daphne F YoungGeneral Practice Residency Program, Meharry Medical College, Nashville, Tennessee.
Prashant KumarDepartment of Oral Biology, Meharry Medical College, Nashville, Tennessee.
Hua XieDepartment of Oral Biology, Meharry Medical College, Nashville, Tennessee.ORCID 0000-0002-1712-3256
Meharry Medical College · USVanderbilt University · USUniversity of Louisville · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Maureen Sanderson · 2017 to 2026
$48.2M
Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
MOLECULAR ASPECTS OF ORAL PLAQUE FORMATIONR01DE012505 · NIDCR · UNIVERSITY OF WASHINGTON · PI Richard J Lamont, JAN S POTEMPA · 1998 to 2026
$9.5M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Meharry RCMI Program in Women's Health ResearchG12MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI HILDRETH, JAMES E · 2012 to 2016
$7.8M
Structural Biology of Multi-Domain Proteins and Multi-Protein Machinery in DNA Replication and RepairR35GM118089 · NIGMS · VANDERBILT UNIVERSITY · PI WALTER J. CHAZIN · 2016 to 2026
$4.9M
Probing Polymicrobial Synergy Using hihg Throughout GenomicsR01DE023193 · NIDCR · UNIVERSITY OF TEXAS AT AUSTIN · PI LAMONT, RICHARD J, WHITELEY, MARVIN · 2013 to 2023
$4.7M
Intergeneric Signaling Molecules of S. cristatusR01DE014699 · NIDCR · MEHARRY MEDICAL COLLEGE · PI XIE, HUA · 2004 to 2008
$858k
Identification of a novel signaling network in Porphyromonas gingivalisR21DE020915 · NIDCR · MEHARRY MEDICAL COLLEGE · PI XIE, HUA · 2011 to 2012
$424k
Distribution correlation of P. gingivalis and S. cristatus in dental plaqueR21DE022428 · NIDCR · MEHARRY MEDICAL COLLEGE · PI XIE, HUA · 2012 to 2013
$408k
Identification of cyclic di-GMP signaling components in P. gingivalisR21DE025332 · NIDCR · MEHARRY MEDICAL COLLEGE · PI XIE, HUA · 2015 to 2016
$400k
NIDCR NIH HHS R01 DE012505NIDCR NIH HHS R01 DE014699NIDCR NIH HHS R01 DE023193NIDCR NIH HHS R21 DE020915NIDCR NIH HHS R21 DE022428NIDCR NIH HHS R21 DE025332NIGMS NIH HHS R35 GM118089NIGMS NIH HHS T32 GM008320NIMHD NIH HHS G12 MD007586NIMHD NIH HHS U54 MD007586NIMHD NIH HHS U54 MD007593
6 · The paper itself

Abstract

Porphyromonas gingivalis is a keystone bacterium in the oral microbial communities that elicits a dysbiosis between the microbiota and the host. Therefore, inhibition of this organism in dental plaques has been one of the strategies for preventing and treating chronic periodontitis. We previously identified a Streptococcal ArcA derived Anti-P gingivalils Peptide (SAPP) that in vitro, is capable of repressing the expression of several virulence genes in the organism. This leads to a significant reduction in P gingivalis virulence potential, including its ability to colonize on the surface of Streptococcus gordonii, to invade human oral epithelial cells, and to produce gingipains. In this study, we showed that SAPP had minimal cytotoxicity to human oral keratinocytes and gingival fibroblasts. We observed that SAPP directly bound to the cell surface of P gingivalis, and that alterations in the sequence at the N-terminus of SAPP diminished its abilities to interact with P gingivalis cells and repressed the expression of virulence genes. Most strikingly, we demonstrated using an ex-vivo assay that besides its inhibitory activity against P gingivalis colonization, SAPP could also reduce the levels of several other oral Gram-negative bacteria strongly associated with periodontitis in multispecies biofilms. Our results provide a platform for the development of SAPP-targeted therapeutics against chronic periodontitis.

Indexed as

Adhesins, BacterialBacterial AdhesionBiofilmsCell MembraneCysteine EndopeptidasesDental PlaqueFibroblastsGingipain Cysteine EndopeptidasesHumansPeptidesPeriodontitisPorphyromonas gingivalisVirulenceAdhesins, BacterialCysteine EndopeptidasesGingipain Cysteine EndopeptidasesPeptidesbiofilmsoral microbiologyperiodontal diseaseporphyromonas

Identifiers

PMID30298683
PMCPMC6246824
OpenAlexW2897935734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.